China's A-share innovative-drug sector opened sharply higher on August 20, with multiple stocks hitting limit-up, while Moderna surged 177% overnight after Moderna and Merck announced their melanoma skin-cancer vaccine met its primary endpoint in a large trial.
Jin1008/20, 08:28 AM
Related assets
Coming up for MRNA
Explore next
Latest MRNA news
Jin1010/23, 05:33 AM
Jin1010/23, 03:02 AM
Jin1010/23, 12:41 AM